Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|December 13, 2023
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trialSeef Abdalla, Alexandra Compagnucci, Yoann Riault, et al.
Translational Psychiatry|January 13, 2021
A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker dataJakub Tomasik, Sung Yeon Sarah Han, Giles Barton-Owen, et al.
Biomarker Insights|June 4, 2010
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophreniaEmanuel Schwarz, Rauf Izmailov, Michael Spain, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stressGeorgia E Hodes, Madeline L Pfau, Marylene Leboeuf, et al.
Translational Psychiatry|October 31, 2022
Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markersJihan K Zaki, Santiago G Lago, Nitin Rustogi, et al.
Cell Reports|August 19, 2014
Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticityAmit Agarwal, Mingyue Zhang, Irina Trembak-Duff, et al.
The Journal of Allergy and Clinical Immunology|July 5, 2016
Current concepts in chronic inflammatory diseases: Interactions between microbes, cellular metabolism, and inflammationHolger Garn, Sabine Bahn, Bernhard T Baune, et al.
The Lancet. HIV|February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trialHylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
The Lancet. HIV|July 22, 2022
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trialAnna Turkova, Hylke Waalewijn, Man K Chan, et al.
Contemporary Clinical Trials|April 18, 2024
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 yearsAnna Turkova, Man K Chan, Cissy Kityo, et al.
Pageof 22